Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.
about
ESUR prostate MR guidelines 2012Limitations and Prospects for Diffusion-Weighted MRI of the ProstateDiffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibilityActive surveillance and focal therapy for low-intermediate risk prostate cancerThe current and future role of magnetic resonance imaging in prostate cancer detection and managementNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismThe role of magnetic resonance imaging in the diagnosis and management of prostate cancerRole of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerProstate cancer: ESMO Consensus Conference Guidelines 2012The utility and limitations of contrast-enhanced ultrasound for the diagnosis and treatment of prostate cancerComputed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation.Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer.Practical estimate of gradient nonlinearity for implementation of apparent diffusion coefficient bias correction.Information-based ranking of 10 compartment models of diffusion-weighted signal attenuation in fixed prostate tissue.Review of Prostate Imaging Reporting and Data System version 2.Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.Focal therapy for prostate cancer: rationale and treatment opportunities.Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy.Imaging and intervention in prostate cancer: Current perspectives and future trendsEvolution from active surveillance to focal therapy in the management of prostate cancer.Evaluation of prostate segmentation algorithms for MRI: the PROMISE12 challengeProstate MRI: access to and current practice of prostate MRI in the United States.Focal laser ablation of prostate cancer: definition, needs, and future.A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT)Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathwayThe future perspectives in transrectal prostate ultrasound guided biopsyLogistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRI.Performance comparison of 1.5-T endorectal coil MRI with 3.0-T nonendorectal coil MRI in patients with prostate cancer.Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.Focal therapy for prostate cancer - where are we in 2011?Prognostic Utility of PET in Prostate Cancer.ProstateAnalyzer: Web-based medical application for the management of prostate cancer using multiparametric MR imaging.The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate CancerProstate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging
P2860
Q24620926-441C7386-5FFE-403C-990A-E378BC527C86Q26744802-631F648D-FEAB-4414-BE5C-C061DA44881DQ26770403-5DF7FD94-94D2-4A10-9B81-A3E0D76BB9EAQ26773641-4A938B0F-8E2E-4FA6-BA5A-052763419C98Q26773645-2DB00116-E7E1-4ECD-B451-3CAA80CDC410Q26774456-AACB1004-F691-4C69-B00B-0556069C4287Q26849794-A08BD7DF-83EA-4B20-9337-3D211B94F7A2Q26998938-8AC00EEF-B531-4E64-8B3F-8C01765DE5B6Q27022847-A7E2FE27-01D7-4F6D-9F6E-A0E8908DF03FQ28085279-B57E574F-E874-4D4A-B635-32D12CFC0F7EQ30300480-BFFFEFCF-DF17-4473-B6CE-2FE0605ABD05Q30355460-6473BAAE-2060-4183-A0C7-4F278C95FA4DQ30422070-91847C01-45C9-43AF-8986-AF1C7C860D6CQ30444755-3C535B66-5D88-45CE-8E70-58655B2B8D97Q30890815-C35BCF5A-6505-482F-B44A-B6AF202FCCEBQ31061248-293466B6-E0D1-4D62-870A-6B64818BFF0DQ31131775-4495A686-CA5A-4A62-BE1A-CA3FE0EEFF4FQ31137158-28C2BE75-9026-4FE6-98AF-A755B39B26BEQ33702259-A3A1B61E-BB7F-4D27-8C4A-335349B5E216Q33723568-6E460033-5D0F-45B3-90B4-B7CC980C8032Q33783620-BF78E13E-CB56-4386-9EB3-EAE73D4BCA0EQ33870183-A013ACB0-9022-46CE-AB6E-1FE67F8E5EE0Q33890175-E29F48D0-D284-4100-8F36-1FB4B12592AEQ33891781-13FB151E-CF09-4840-9977-636DCD9E38CAQ33933490-0F4D2622-931E-42A3-B982-4FC08AD32A42Q34065836-0FA4772E-0D3D-43F4-B916-7AD673810B42Q34217791-8051C76F-17DD-43F9-BA35-F77FBAE00E24Q34292322-2072D07B-CE54-4DCE-B96C-E52478CC62A6Q34306878-09657A15-4B1C-4802-973D-C72C8A65DFDEQ34761435-4F9B81DD-990E-4A27-A381-9DFBB29F9D8EQ34864858-B0F71166-B68F-48C0-8015-0E383E4B33CDQ34924490-279EB5B7-FC6F-4317-B97D-33A0CD895A18Q35163748-49B7E9F6-024B-4742-848C-DE3A7A768AE5Q35178690-62B4F625-86C7-4D7E-B0D0-829F37180DA5Q35220196-4CD41ECC-E3DE-4E64-AEE1-228020FF5920Q35244433-19B11CB3-A0B3-4364-A0C1-3D14E41743A9Q35566952-08165F19-42CB-45D8-8ECC-EDE06D7019E3Q35600604-AC9EF2A9-1957-41EC-A1D5-B574402D9E4BQ35661505-EFFD0B4E-A3FD-4772-8224-DEE6339FA9DEQ35670525-D1C3EE36-F2FF-4C5C-A9F5-2BA8C58F64F8
P2860
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Magnetic resonance imaging for ...... a European consensus meeting.
@en
Magnetic resonance imaging for ...... a European consensus meeting.
@nl
type
label
Magnetic resonance imaging for ...... a European consensus meeting.
@en
Magnetic resonance imaging for ...... a European consensus meeting.
@nl
prefLabel
Magnetic resonance imaging for ...... a European consensus meeting.
@en
Magnetic resonance imaging for ...... a European consensus meeting.
@nl
P2093
P50
P1433
P1476
Magnetic resonance imaging for ...... a European consensus meeting.
@en
P2093
Alex Kirkham
Anwar R Padhani
Aslam S Sohaib
Brendan Carey
Clare Allen
Hashim U Ahmed
Jan van der Meulen
Jelle O Barentsz
Jurgen J Futterer
Louise Dickinson
P304
P356
10.1016/J.EURURO.2010.12.009
P407
P577
2010-12-21T00:00:00Z